Evidence map›Paper›PMID 42124607›Full record

ArticlebioRxiv : the preprint server for biology2026

A Framework for Autonomous AI-Driven Drug Discovery.

Douglas W Selinger, Timothy R Wall, Eleni Stylianou, Ehab M Khalil, Jedidiah Gaetz, Oren Levy

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Douglas W SelingerPlex Research Inc., Cambridge, MA, USA.
Timothy R WallPlex Research Inc., Cambridge, MA, USA.
Eleni StylianouPlex Research Inc., Cambridge, MA, USA.
Ehab M KhalilPlex Research Inc., Cambridge, MA, USA.
Jedidiah GaetzPlex Research Inc., Cambridge, MA, USA.
Oren LevyDepartment of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Funding

AI-guided Intestinal stem cell activation for mucosal restoration in ulcerative colitisR21AI196527 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Oren Levy · 2026 to 2026
$480k
NIAID NIH HHS R21 AI196527
6 · The paper itself

Abstract

The exponential increase in biomedical data offers unprecedented opportunities for drug discovery, yet overwhelms traditional data analysis methods, limiting the pace of new drug development. Here we introduce a framework for autonomous artificial intelligence (AI)-driven drug discovery that integrates knowledge graphs with large language models (LLMs). It is capable of planning and carrying out automated drug discovery programs at a massive scale while providing details of its research strategy, progress, and all supporting data. At the heart of this framework lies the focal graph - a novel construct that harnesses centrality algorithms to distill vast, noisy datasets into concise, transparent, data-driven hypotheses. We demonstrate that even small-scale applications of this highly scalable approach can yield novel, transparent insights relevant to multiple stages of the drug discovery process, including chemical structure-based target prediction, and present the implementation of a system which autonomously plans and executes a multi-step target discovery workflow.

Indexed as

Artificial IntelligenceAutonomous AIBioinformaticsCheminformaticsFGsFocal GraphsKGsKnowledge GraphsLarge Language ModelsLLMs

Identifiers

PMID42124607
PMCPMC13160015

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.